BreakThrough T1D/ADS Joint Symposium - Every stage and age of T1D: problem - challenge - solution

Tracks
Breakout 1: Arena 1
Wednesday, August 20, 2025
4:00 PM - 6:00 PM
Arena 1

Speaker

Dr Dorota Pawlak
Chief Scientific Officer
Breakthrough T1d

Breakthrough T1D’s Research Vision over the next five years

4:00 PM - 4:10 PM

Biography

Agenda Item Image
Prof Jenny Couper
Head , Discipline of Paediatrics, University of Adelaide
Women's and Children's Hospital

Delivering optimal care of early type 1 diabetes in Australia

4:10 PM - 4:32 PM

Biography

Jenny Couper is a clinician researcher and paediatric endocrinologist. She is Head of the Discipline of Paediatrics, University of Adelaide and was Head of the Diabetes and Endocrinology Department, Women’s and Children’s Hospital, SA. She leads the Australian early life at-risk cohort (ENDIA study www.endia.org.au) and the Breakthrough T1D Australian monitoring program of children with early type 1 diabetes. She co-chairs the ISPAD early type 1` diabetes advisory group and is a co –author of international guidelines for the management of type 1 diabetes in children and adolescents.
Agenda Item Image
Prof John Wentworth
Endocrinologist and Senior Clinical Research Fellow
Royal Melbourne Hospital and St Vincent's Institute

Active and Emerging Immune Therapy Targets

4:32 PM - 4:54 PM

Biography

Prof Thomas Kay
Director
St Vincent's Institute of Medical Research

Immunological barriers to cell therapy in type 1 diabetes, lessons from clinical trials and autoimmunity research

4:54 PM - 5:16 PM

Biography

Agenda Item Image
Prof Toby Coates
Director Of Transplantation
Royal Adelaide Hospital

Delivering beta cell therapies, innovations in transplantation

5:16 PM - 5:38 PM

Biography

P. Toby Coates MD PhD is the Director of Kidney, Pancreas and Islet Transplantation at the Royal Adelaide Hospital and Professor at the University of Adelaide. He is a translational clinician scientist and transplant nephrologist. He was a foundation member of the Australian Islet Consortium in 2006. In 2017 his team undertook Australia’s first paediatric total pancreatectomy and islet auto transplant (TP-IAT) for Hereditary Pancreatitis in Adelaide. He founded Beta Cell Technologies for the development of alternative sites for islet cell transplantation. He is the principal investigator in the HEPATA study (Hereditary Pancreatitis and Islet Auto Transplantation Trials in Australia).
Dr Jennifer Snaith
Endocrinologist
Garvan Institute of Medical Research

Role of Adjunct Therapies in Type 1 Diabetes Management

5:38 PM - 6:00 PM

Biography

Dr Dorota Pawlak
Chief Scientific Officer
Breakthrough T1d

Close

6:00 PM - 6:00 PM

Biography

Dr Dorota Pawlak
Chief Scientific Officer
Breakthrough T1d

Chairperson

Biography

loading